European equities slipped slightly on Thursday, with regional benchmarks trading in the red despite overnight strength in Asia and a rebound on Wall Street.

Losses across the continent were contained after new data showed that Germany’s industrial production returned to growth in September, led by a recovery in the automotive sector.

According to Destatis, output rose 1.3% month-on-month, rebounding from a 3.7% decline in August, signaling that Europe’s largest economy may be regaining some momentum.

At mid-morning, the CAC 40 in France fell 0.6%, the DAX in Germany eased 0.2%, and the FTSE 100 in the U.K. edged down 0.1%.

In corporate developments, A.P. Møller-Mærsk (TG:DP4A) shares dropped sharply after the Danish shipping giant posted a decline in third-quarter net income, citing weaker freight rates and ongoing global trade challenges.

Commerzbank (TG:CBK) moved higher even though its Q3 earnings came in below analysts’ forecasts, while Skanska (TG:SKNB) slumped after the Swedish builder reported profit short of market expectations.

In contrast, Zalando (BIT:1ZAL) surged after a strong third quarter boosted by its July 2025 acquisition of About You, which strengthened its presence in the online fashion market.

Henkel (TG:HEN) also climbed after the consumer goods and adhesives manufacturer reported solid organic sales growth in the quarter.

Elsewhere, ArcelorMittal (EU:MT) advanced after reporting a 31.35% increase in net income for the September quarter, while Swisscom (TG:SWJ) gained on the back of a 36.9% jump in revenue to CHF 11.175 billion in the first nine months of 2025.

Meanwhile, AstraZeneca (LSE:AZN) traded higher after the British pharmaceutical group reaffirmed its full-year outlook.

This content is for informational purposes only and does not constitute financial, investment, or other professional advice. It should not be considered a recommendation to buy or sell any securities or financial instruments. All investments involve risk, including the potential loss of principal. Past performance is not indicative of future results. You should conduct your own research and consult with a qualified financial advisor before making any investment decisions.
Some portions of this content may have been generated or assisted by artificial intelligence (AI) tools and been reviewed for accuracy and quality by our editorial team.